Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 126,906	$ 90,601
Other current assets	17,919	5,321
Total current assets	144,825	95,922
Patents, net of accumulated amortization of $1,784,718 and $1,625,846, respectively	4,272,282	1,131,154
Total assets	4,417,107	1,227,076
Current liabilities
Accounts payable and accrued liabilities	171,374	148,533
Loans payable	138,000	138,000
Funding liabilities	9,397,344	5,453,204
Loan payable - related party	2,796,500	2,796,500
Warrant liability	153,994	145,428
Accrued interest	1,039,849	904,573
Total current liabilities	13,697,061	9,586,238
Non-current liabilities
Loan payable – SBA	150,000	150,000
Purchase price of patents	53,665	53,665
Total liabilities	13,900,726	9,789,903
Commitments and contingencies (Note 2)
Stockholders’ deficit:
Preferred stock, par value $0.00003 per share - authorized 10,000,000 shares - no shares issued and outstanding
Common stock, par value $0.00003 per share; authorized 30,000,000 at March 31, 2023 and December 31, 2022; shares issued and outstanding 5,331,973 at March 31, 2023 and December 31, 2022	160	160
Additional paid-in capital	17,644,852	17,626,279
Accumulated deficit	(27,128,859)	(26,189,494)
Total Quest Patent Research Corporation stockholders’ deficit	(9,483,847)	(8,563,055)
Non-controlling interest in subsidiary	228	228
Total stockholders’ deficit	(9,483,619)	(8,562,827)
Total liabilities and stockholders’ deficit	$ 4,417,107	$ 1,227,076